Japan Lifeline Co., Ltd. logo

Japan Lifeline Co., Ltd.

7575.T

JPXHealthcareMedical - Devices

Latest quote

¥1,569

−¥7.00 · -0.44%

Aug 24, 3:30 PM JST

7575.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal temperature monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
JP
CEO
Keisuke Suzuki
Listed since
Jan 4, 2000
Employees
1,304

Market position

Volume
89.2K
0.46× average
Average volume
192.49K
Average daily volume
Market cap
110.07B JPY
Beta
0.36
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
11.76×
P/B (TTM)
1.71×
P/S (TTM)
1.82×
Dividend yield
3.44%

Profitability & efficiency

Gross margin
57.69%
Operating margin
19.16%
Net margin
15.47%

Financial health

Debt / equity
0.06×
Altman Z-score
8.36
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends64%45%27%9%Gross margin, FY2021: 54.13%Gross margin, FY2022: 56.01%Gross margin, FY2023: 59.12%Gross margin, FY2024: 58.48%Gross margin, FY2025: 58.26%Operating margin, FY2021: 19.35%Operating margin, FY2022: 20.94%Operating margin, FY2023: 21.48%Operating margin, FY2024: 22.12%Operating margin, FY2025: 21.26%Net margin, FY2021: 14.54%Net margin, FY2022: 13.32%Net margin, FY2023: 14.63%Net margin, FY2024: 16.46%Net margin, FY2025: 15.80%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 54.13%. Gross margin FY2022 56.01%. Gross margin FY2023 59.12%. Gross margin FY2024 58.48%. Gross margin FY2025 58.26%. Operating margin FY2021 19.35%. Operating margin FY2022 20.94%. Operating margin FY2023 21.48%. Operating margin FY2024 22.12%. Operating margin FY2025 21.26%. Net margin FY2021 14.54%. Net margin FY2022 13.32%. Net margin FY2023 14.63%. Net margin FY2024 16.46%. Net margin FY2025 15.80%.

Income trends

Revenue

59.19B JPY+4.55%

Operating income

12.59B JPY+0.52%

Net income

9.35B JPY+0.35%
Income trends across reported periods64.42B JPY43.5B JPY22.58B JPY1.66B JPYRevenue, FY2021: 51.47B JPYRevenue, FY2022: 51.75B JPYRevenue, FY2023: 51.38B JPYRevenue, FY2024: 56.61B JPYRevenue, FY2025: 59.19B JPYOperating income, FY2021: 9.96B JPYOperating income, FY2022: 10.84B JPYOperating income, FY2023: 11.04B JPYOperating income, FY2024: 12.52B JPYOperating income, FY2025: 12.59B JPYNet income, FY2021: 7.48B JPYNet income, FY2022: 6.89B JPYNet income, FY2023: 7.52B JPYNet income, FY2024: 9.32B JPYNet income, FY2025: 9.35B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 51.47B JPY. Revenue FY2022 51.75B JPY. Revenue FY2023 51.38B JPY. Revenue FY2024 56.61B JPY. Revenue FY2025 59.19B JPY. Operating income FY2021 9.96B JPY. Operating income FY2022 10.84B JPY. Operating income FY2023 11.04B JPY. Operating income FY2024 12.52B JPY. Operating income FY2025 12.59B JPY. Net income FY2021 7.48B JPY. Net income FY2022 6.89B JPY. Net income FY2023 7.52B JPY. Net income FY2024 9.32B JPY. Net income FY2025 9.35B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue59.19B JPY56.61B JPY51.38B JPY51.75B JPY51.47B JPY
Cost of goods sold24.71B JPY23.51B JPY21.01B JPY22.77B JPY23.61B JPY
Gross profit34.48B JPY33.1B JPY30.38B JPY28.99B JPY27.86B JPY
Research and development3.1B JPY2.85B JPY2.37B JPY2.32B JPY2.16B JPY
Selling, general, and administrative18.79B JPY17.73B JPY16.97B JPY15.83B JPY15.74B JPY
Operating expenses21.9B JPY20.58B JPY19.34B JPY18.15B JPY17.9B JPY
Interest income165M JPY196M JPY156M JPY105M JPY63M JPY
Interest expense34M JPY36M JPY26M JPY34M JPY76M JPY
Depreciation and amortization1.97B JPY2.1B JPY1.79B JPY1.88B JPY1.93B JPY
Operating income12.59B JPY12.52B JPY11.04B JPY10.84B JPY9.96B JPY
Net income9.35B JPY9.32B JPY7.52B JPY6.89B JPY7.48B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
32.93

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates3935.2231.4527.67Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Oct 31, 2024: actual 29.89, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Jan 31, 2025: actual 37.5, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 7, 2025: actual 32.06, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 32.85, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 29, 2025: actual 35.23, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 30, 2026: actual 29.17, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 7, 2026: actual 36.05, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 30, 2026: actual 32.93, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates16.54B15.41B14.29B13.16BQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 31, 2025: actual 14.83B JPY, estimate 14.66B JPY, surprise +1.11%, Beat. Q2 2025, reported May 7, 2025: actual 13.8B JPY, estimate 14.32B JPY, surprise -3.64%, Miss. Q3 2025, reported Jul 31, 2025: actual 14.62B JPY, estimate 14.8B JPY, surprise -1.24%, Miss. Q4 2025, reported Oct 29, 2025: actual 14.67B JPY, estimate 14.7B JPY, surprise -0.21%, Miss. Q1 2026, reported Jan 30, 2026: actual 15.12B JPY, estimate 15.31B JPY, surprise -1.24%, Miss. Q2 2026, reported May 7, 2026: actual 14.78B JPY, estimate 14.56B JPY, surprise +1.54%, Beat. Q3 2026, reported Jul 30, 2026: actual 15.9B JPY, estimate 15.6B JPY, surprise +1.95%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 15.4B JPY, surprise —, Comparison unavailable.

7575.T peers

Continue in GoAI

Research 7575.T

research.disclaimer